{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:19Z","timestamp":1785542419597,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06302-4","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:02:13Z","timestamp":1741838533000},"page":"1669-1678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolomics and machine learning approaches for diagnostic biomarkers screening in systemic light chain amyloidosis"],"prefix":"10.1007","volume":"104","author":[{"given":"Weiwei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"1","key":"6302_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"G Merlini","year":"2018","unstructured":"Merlini G et al (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4(1):38","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"6302_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13023-022-02414-6","volume":"17","author":"N Kumar","year":"2022","unstructured":"Kumar N et al (2022) Global epidemiology of amyloid light-chain amyloidosis. Orphanet J Rare Dis 17(1):278","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"6302_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/ejh.13679","volume":"107","author":"LL Hester","year":"2021","unstructured":"Hester LL et al (2021) Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019. Eur J Haematol 107(4):428\u2013435","journal-title":"Eur J Haematol"},{"issue":"2","key":"6302_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","volume":"11","author":"KL McCausland","year":"2018","unstructured":"McCausland KL et al (2018) Light Chain (AL) Amyloidosis: The Journey to Diagnosis. Patient 11(2):207\u2013216","journal-title":"Patient"},{"issue":"11","key":"6302_CR5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ajh.23827","volume":"89","author":"TV Kourelis","year":"2014","unstructured":"Kourelis TV et al (2014) Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias. Am J Hematol 89(11):1051\u20131054","journal-title":"Am J Hematol"},{"issue":"4","key":"6302_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ejh.13472","volume":"105","author":"A Schulman","year":"2020","unstructured":"Schulman A et al (2020) Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis. Eur J Haematol 105(4):495\u2013501","journal-title":"Eur J Haematol"},{"key":"6302_CR7","unstructured":"Kyle RA, Greipp PR,  Amyloidosis (AL) (1983) Clinical and laboratory features in 229 cases. Mayo Clin Proc 58(10):665\u201383."},{"issue":"8","key":"6302_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41408-021-00529-w","volume":"11","author":"A Staron","year":"2021","unstructured":"Staron A et al (2021) Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J 11(8):139","journal-title":"Blood Cancer J"},{"issue":"11","key":"6302_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jchf.2019.07.007","volume":"7","author":"CD Barrett","year":"2019","unstructured":"Barrett CD et al (2019) A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis. JACC Heart Fail 7(11):958\u2013966","journal-title":"JACC Heart Fail"},{"issue":"23","key":"6302_CR10","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood.2020006913","volume":"136","author":"G Palladini","year":"2020","unstructured":"Palladini G, Milani P, Merlini G (2020) Management of AL amyloidosis in 2020. Blood 136(23):2620\u20132627","journal-title":"Blood"},{"issue":"12","key":"6302_CR11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","volume":"27","author":"AC Schrimpe-Rutledge","year":"2016","unstructured":"Schrimpe-Rutledge AC et al (2016) Untargeted Metabolomics Strategies-Challenges and Emerging Directions. J Am Soc Mass Spectrom 27(12):1897\u20131905","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"6302_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","volume":"85","author":"M Mamas","year":"2011","unstructured":"Mamas M et al (2011) The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 85(1):5\u201317","journal-title":"Arch Toxicol"},{"issue":"3","key":"6302_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/metabo3030552","volume":"3","author":"RD Beger","year":"2013","unstructured":"Beger RD (2013) A review of applications of metabolomics in cancer. Metabolites 3(3):552\u2013574","journal-title":"Metabolites"},{"issue":"12","key":"6302_CR14","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538\u2013e548","journal-title":"Lancet Oncol"},{"issue":"9","key":"6302_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S et al (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 30(9):989\u2013995","journal-title":"J Clin Oncol"},{"issue":"18","key":"6302_CR16","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","volume":"22","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A et al (2004) Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 22(18):3751\u20133757","journal-title":"J Clin Oncol"},{"issue":"15","key":"6302_CR17","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","volume":"124","author":"G Palladini","year":"2014","unstructured":"Palladini G et al (2014) A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood 124(15):2325\u20132332","journal-title":"Blood"},{"issue":"4","key":"6302_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA et al (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol 79(4):319\u2013328","journal-title":"Am J Hematol"},{"issue":"15","key":"6302_CR19","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420","journal-title":"J Clin Oncol"},{"issue":"26","key":"6302_CR20","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A et al (2015) Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J Clin Oncol 33(26):2863\u20132869","journal-title":"J Clin Oncol"},{"key":"6302_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-0716-2699-3_15","volume":"2571","author":"K Pietrowska","year":"2023","unstructured":"Pietrowska K et al (2023) Metabolomics Analysis of Aqueous Humor Based on Liquid Chromatography-Mass Spectrometry. Methods Mol Biol 2571:149\u2013155","journal-title":"Methods Mol Biol"},{"issue":"9","key":"6302_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","volume":"126","author":"SH Shah","year":"2012","unstructured":"Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126(9):1110\u20131120","journal-title":"Circulation"},{"issue":"11","key":"6302_CR23","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41592-021-01303-3","volume":"18","author":"L Chen","year":"2021","unstructured":"Chen L et al (2021) Metabolite discovery through global annotation of untargeted metabolomics data. Nat Methods 18(11):1377\u20131385","journal-title":"Nat Methods"},{"issue":"24","key":"6302_CR24","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1242\/jcs.204396","volume":"130","author":"N Aviram","year":"2017","unstructured":"Aviram N, Schuldiner M (2017) Targeting and translocation of proteins to the endoplasmic reticulum at a glance. J Cell Sci 130(24):4079\u20134085","journal-title":"J Cell Sci"},{"issue":"3","key":"6302_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.devcel.2008.07.007","volume":"15","author":"Y Peng","year":"2008","unstructured":"Peng Y, Weisman LS (2008) The cyclin-dependent kinase Cdk1 directly regulates vacuole inheritance. Dev Cell 15(3):478\u2013485","journal-title":"Dev Cell"},{"issue":"2","key":"6302_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cell.2010.06.006","volume":"142","author":"A Babour","year":"2010","unstructured":"Babour A et al (2010) A surveillance pathway monitors the fitness of the endoplasmic reticulum to control its inheritance. Cell 142(2):256\u2013269","journal-title":"Cell"},{"key":"6302_CR27","doi-asserted-by":"crossref","unstructured":"Pi\u00f1a FJ,  Niwa M  (2015) The ER Stress Surveillance (ERSU) pathway regulates daughter cell ER protein aggregate inheritance. Elife  4.","DOI":"10.7554\/eLife.06970"},{"issue":"2","key":"6302_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1091\/mbc.E20-08-0558","volume":"32","author":"JT Chao","year":"2021","unstructured":"Chao JT, Pina F, Niwa M (2021) Regulation of the early stages of endoplasmic reticulum inheritance during ER stress. Mol Biol Cell 32(2):109\u2013119","journal-title":"Mol Biol Cell"},{"issue":"2","key":"6302_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1083\/jcb.201708068","volume":"217","author":"F Pi\u00f1a","year":"2018","unstructured":"Pi\u00f1a F et al (2018) Sphingolipids activate the endoplasmic reticulum stress surveillance pathway. J Cell Biol 217(2):495\u2013505","journal-title":"J Cell Biol"},{"issue":"15","key":"6302_CR30","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1182\/blood-2016-08-730978","volume":"129","author":"L Oliva","year":"2017","unstructured":"Oliva L et al (2017) The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity. Blood 129(15):2132\u20132142","journal-title":"Blood"},{"issue":"1","key":"6302_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0092-8674(01)00423-8","volume":"106","author":"AE McBride","year":"2001","unstructured":"McBride AE, Silver PA (2001) State of the arg: protein methylation at arginine comes of age. Cell 106(1):5\u20138","journal-title":"Cell"},{"issue":"6","key":"6302_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","volume":"24","author":"P Vallance","year":"2004","unstructured":"Vallance P, Leiper J (2004) Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24(6):1023\u20131030","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"6302_CR33","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1191\/1358863x05vm597oa","volume":"10","author":"T Teerlink","year":"2005","unstructured":"Teerlink T (2005) ADMA metabolism and clearance. Vasc Med 10(Suppl 1):S73-81","journal-title":"Vasc Med"},{"issue":"2","key":"6302_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/157340310791162659","volume":"6","author":"L Sibal","year":"2010","unstructured":"Sibal L et al (2010) The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev 6(2):82\u201390","journal-title":"Curr Cardiol Rev"},{"key":"6302_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.niox.2018.06.004","volume":"78","author":"X Liu","year":"2018","unstructured":"Liu X et al (2018) Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease. Nitric Oxide 78:113\u2013120","journal-title":"Nitric Oxide"},{"issue":"5","key":"6302_CR36","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1096\/fj.201901318R","volume":"34","author":"S Choi","year":"2020","unstructured":"Choi S et al (2020) Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology. Faseb j 34(5):6808\u20136823","journal-title":"Faseb j"},{"issue":"1","key":"6302_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijcard.2009.04.044","volume":"145","author":"RQ Migrino","year":"2010","unstructured":"Migrino RQ et al (2010) Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 145(1):67\u201368","journal-title":"Int J Cardiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06302-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06302-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06302-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:10:47Z","timestamp":1745575847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06302-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6302"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06302-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of PKUFH (2021yan323) and conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}